Twinbeech Capital LP Increases Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Twinbeech Capital LP grew its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 63.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 382,735 shares of the health services provider’s stock after acquiring an additional 149,118 shares during the period. Twinbeech Capital LP owned about 0.22% of Teladoc Health worth $3,479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after acquiring an additional 1,029,829 shares during the period. Point72 Asset Management L.P. grew its position in shares of Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after acquiring an additional 2,813,568 shares during the period. Renaissance Technologies LLC grew its position in shares of Teladoc Health by 15.5% during the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock valued at $51,582,000 after acquiring an additional 763,265 shares during the period. Geode Capital Management LLC grew its position in shares of Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock valued at $35,894,000 after acquiring an additional 22,664 shares during the period. Finally, Maple Rock Capital Partners Inc. grew its position in shares of Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after acquiring an additional 2,331,000 shares during the period. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Up 0.3%

TDOC opened at $7.33 on Wednesday. The firm has a 50-day simple moving average of $7.52 and a two-hundred day simple moving average of $9.34. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21. The company has a market capitalization of $1.29 billion, a PE ratio of -1.27 and a beta of 1.82. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on TDOC shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday, May 1st. Evercore ISI dropped their target price on shares of Teladoc Health from $8.00 to $7.00 and set an “in-line” rating for the company in a report on Thursday, May 1st. Wells Fargo & Company dropped their target price on shares of Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating for the company in a report on Thursday, May 8th. Royal Bank of Canada upped their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Piper Sandler dropped their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $9.71.

Insider Buying and Selling at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the company’s stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.58% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.